| 序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(09-30)
|
归母净利润同比增长(06-30)
|
营业收入同比增长(09-30)
|
营业收入同比增长(06-30)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 19.96 | 29.29 | 24.56 | 2.03 | 2.48% | 177.53 | 18.51% | 10.70% | 4.92% | 3.86% |
| 2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 26.65 | — | — | 2.72 | — | 145.37 | 138.71% | 115.91% | 19.72% | 19.88% |
| 3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 42.9 | 33.44 | 70.02 | 1.89 | 0.81% | 28.60 | -57.44% | -51.28% | -28.60% | -21.57% |
| 4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 8.99 | 83.35 | 68.87 | 4.36 | — | 34.57 | 36.41% | 12.46% | 2.74% | 2.95% |
| 5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 11.59 | — | — | 4.6 | — | 57.71 | 111.50% | 140.35% | 13.68% | 14.75% |
| 6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 7.49 | — | — | 3.28 | — | 48.61 | 14.57% | 7.74% | -1.91% | 6.01% |
| 7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 57.9 | — | — | 2.45 | — | 63.24 | -95.68% | -97.69% | -29.33% | -36.70% |
| 8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 32.8 | — | — | 2.38 | 0.6% | 50.75 | -58.47% | -49.06% | 16.95% | 11.24% |
| 9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 68.59 | 47.24 | 43.76 | 3.45 | 0.23% | 66.25 | 13.21% | 4.45% | 8.09% | 0.18% |
| 10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 38.75 | 120.89 | 45.42 | 2.12 | 1.03% | 46.67 | 163.24% | 123.61% | 25.96% | 32.98% |
| 11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 59.88 | 127.26 | 84.23 | 2.43 | 0.5% | 515.58 | 25.45% | -22.22% | -0.82% | -3.21% |
| 12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 47.38 | 45.2 | 32672.4 | 2.86 | — | 66.80 | -111.14% | -115.88% | -35.33% | -38.04% |
| 13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 70.4 | — | — | 4.58 | — | 94.58 | 76.93% | 81.63% | 5.14% | 3.64% |
| 14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 50.6 | 607.34 | 81.41 | 2.32 | — | 39.45 | 276.14% | 298.69% | 14.29% | 10.69% |
| 15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 98.09 | 37.27 | 34.05 | 2.04 | 1.12% | 353.71 | 12.66% | 23.71% | 11.82% | 18.20% |
| 16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 79.79 | 83.95 | 57.39 | 5.64 | — | 169.23 | 65.09% | 115.55% | 27.18% | 24.20% |
| 17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 33.51 | 33.23 | 39.4 | 4.08 | 0.6% | 595.87 | -19.76% | -37.00% | 14.38% | 14.93% |
| 18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 17.82 | 66.53 | 60.13 | 3.32 | — | 73.06 | 11.90% | -7.12% | 12.92% | 10.11% |
| 19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 10.02 | 134.31 | 521.38 | 3.79 | 0.12% | 38.65 | -49.36% | -48.33% | 5.07% | 5.88% |
| 20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 34.46 | — | — | 2.02 | 0.38% | 45.11 | -297.78% | -72.10% | -6.45% | -3.36% |
| 21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | 58.75 | 37.09 | 49.47 | 5.66 | — | 65.80 | -21.38% | -12.61% | -6.65% | 4.87% |
| 22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 42.81 | 45.59 | 49.76 | 1.4 | 0.56% | 100.09 | -13.96% | -26.54% | 25.81% | 23.48% |
| 23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 52.45 | 38.93 | 34.09 | 3.31 | 0.19% | 41.44 | 20.92% | -1.40% | 2.59% | -1.08% |
| 24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 77.35 | 59.87 | 45.85 | 3.51 | — | 70.30 | 42.79% | 41.60% | 20.67% | 17.91% |
| 25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 34.59 | 282.64 | 131.96 | 4.71 | 0.94% | 48.28 | 127.96% | 54.99% | 31.43% | 32.73% |
| 26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 36.99 | 374.26 | 123.17 | 3.41 | 0.08% | 277.23 | 214.79% | 135.90% | -26.23% | -21.28% |
| 27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 99.4 | 31.38 | 19.78 | 4.18 | 1.71% | 2965.85 | 84.84% | 101.92% | 18.61% | 20.64% |
| 28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 25.23 | 196.84 | 88.59 | 6.87 | — | 101.09 | 208.34% | 390.72% | 23.98% | 16.58% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。